Navigation Links
GENSPEED Biotech and axiVEND Announce a Collaboration Agreement
Date:8/1/2019

The GENSPEED platform is a compact, fast and simple system to enable multiplex testing at the point of care. It is fully developed with over 100 units deployed in the field for multiple applications. “Beyond the creation of new tests, with applications into new fields of use, our collaboration with axiVEND will give us a foothold in the USA to better support other nascent test development opportunities,” said Max Sonnleitner, GENSPEED Biotech CEO. “We are excited about our collaboration with axiVEND and the expanded reach this will provide us.”

“The platform itself is very promising, leveraging simple microfluidic consumables and associated ease of use,” said Claude Dufresne, axiVEND CEO. “This platform gives us the fastest and best probability of success to bring novel multiplex test ideas to the market. We will market the new tests under the brand axiTESTtm and use the GENSPEED platform as an OEM system, branded with axiTESTtm colors. This is an exciting phase for both companies.”

About GENSPEED Biotech
GENSPEED Biotech was founded in 2016 as a spin-off company of Greiner Bio-One. We develop, produce and distribute IVD-certified rapid testing solutions based on the patented GENSPEED® technology.. Currently, nine highly qualified employees are devoted to the development, production and sales of in-vitro diagnostics for the rapid identification of various pathogens. With its novel combination of microfluidics, miniaturized opto-electronics and automation GENSPEED® enables the simultaneous detection of multiple analytes at the point of care within a few minutes. GENSPEED® may be used for nucleic acid-based genetic testing as well as for protein analyses. Thus, the platform facilitates the rapid identification of defined bacteria or viruses as well as the quantitation of certain biomarkers in blood or other biological material. For additional information please visit http://www.genspeed-biotech.com.

About axiVEND
While newly founded in 2019, axiVEND is built on the concept of truth in vending. From the Greek “axios” for truthfulness, axiVEND promises to provide the very best solutions, with proven field performance, to the worlds of diagnostics and multiplex assays. Leveraging an expanded network throughout North and South America, axiVEND will soon be positively impacting life science industries in general. The early axiVEND portfolio encompasses best-in-class M2 Automation ultra-low volume high-precision liquid deposition technologies, the latest offerings in colorimetric and fluorescence multiplex array readers, unique high-performance surface coatings for superior protein functional activity, and the next generation label-free multiplex reader. For additional information please visit the axiVEND website at http://www.axivend.com, and follow us on LinkedIn.

Read the full story at https://www.prweb.com/releases/genspeed_biotech_and_axivend_announce_a_collaboration_agreement/prweb16479709.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. KMK Consulting, Inc. Expands Presence in Boston to Help Biotechnology Companies from Pre-Launch to Commercialization
2. Lifecycle Biotechnologies Announces Cellular Agriculture Expansion
3. Swiss Biotech Gnubiotics, Announces Global Launch of GNU100 the First Microbiome Specialty Ingredient for Companion Animal Gut Health
4. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
5. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
6. Lifecycle Biotechnologies Announces Promotion of Cindy Baptiste to Business Development Manager
7. Lifecycle Biotechnologies Releases Company Catalog
8. Lifecycle Biotechnologies Launches 100-Liter SAFEthread Drum
9. Avastus Opens New Vivarium to Serve the Preclinical Research Needs of Boston’s Biotech Community
10. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
11. Dickinson Wright Attorney Lance Anderson Named Pharmaceuticals and Biotechnology Practice Group Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... provides personalized, easy-to-understand, web-based genetic counseling, today announced that the company has expanded ... to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded ...
(Date:7/19/2019)... ... 2019 , ... VetStem Biopharma has long been a leader in ... result of a two-year research collaboration with Calidi Biotherapeutics, VetStem has signed a worldwide ... VetStem should be able to fast-track this cancer therapy for use in dogs ...
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... BETHESDA, Md. and ROANOKE, Va. (PRWEB) , ... ... ... virtual care optimized for microlearning engagement, and Carilion Clinic, a national leader in ... leveraging the latest in virtual care. , Mytonomy recently deployed its ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study ... stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying their ... mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. This ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms of ... demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen ... engineered T cell receptors known as “CARs”. The CAR enables the final product to ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... on Data Integrity on July 08-09, 2019 in Boston, MA. This peer recommended ... medical device organizations. , The training will kick off with a compendial treatment ...
Breaking Biology Technology: